A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides

Peptides

Volumn 22, Issue 11, 2001, Pages 1693-1711

  Eto, Tanenao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Adrenomedullin (AM); Cardiac remodeling; Diuresis; Heart failure; Hypertension; Proadrenomedullin N terminal 20 peptide (PAMP); Vasoactive substance; Vasodilatation

Indexed keywords

ADENYLATE CYCLASE; ADRENOMEDULLIN; CALCITONIN RECEPTOR; CYCLIC AMP; CYCLIC GMP; PROADRENOMEDULLIN; RECEPTOR ACTIVITY MODIFYING PROTEIN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CELL GROWTH; DIURESIS; GENE STRUCTURE; GENE TARGETING; HEART AFTERLOAD; HEART MUSCLE CONTRACTILITY; HEART PRELOAD; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; KIDNEY DISEASE; NEPHROSCLEROSIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SHEAR STRESS; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; TISSUE DISTRIBUTION; VASODILATATION; YOLK SAC;

ADRENOMEDULLIN; ANIMALS; ANTIHYPERTENSIVE AGENTS; GENETIC ENGINEERING; HUMANS; MODELS, BIOLOGICAL; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN PRECURSORS; PROTEINS; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; VASODILATOR AGENTS;

EID: 0035685215     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(01)00513-7     Document Type: Article

References (194)

1. A cDNA encoding the calcitonin gene-related peptide type 1 receptor
2. Proadrenomedullin N-terminal 20 peptide (PAMP) inhibits proliferation of human neuroblastoma TGW cells
3. Proadrenomedullin N-terminal 20 peptide inhibits aldosterone secretion of human adrenocortical, and Conn's adenoma cells: Comparison with adrenomedullin effect
4. Novel distribution of adrenomedullin-immunoreactive cells in human tissues
5. Elevation of two molecular forms of adrenomedullin in plasma and urine in patients with acute myocardial infarction treated with early coronary angioplasty
6. Mechanisms involved in adrenomedullin-mediated modulation of angiotensin signaling in the heart
7. Adrenomedullin and nitrite levels in children with Bartter syndrome
8. Effects of adrenomedullin, calcitonin gene-related peptide, and amylin on cerebral circulation in dogs
9. Receptor-Activity-Modifying Proteins (RAMP) in interaction with receptors of the adrenomedullin peptide family
10. Glycosylation of the calcitonin receptor-like receptor at Asn60 or Asn112 is important for cell surface expression
11. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when co-expressed with human RAMP1
12. Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional adrenomedullin gene
13. CGRP, and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR), and receptor activity modifying proteins (RAMPs) in rat tissues
14. Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats
15. Adrenomedullin attenuates pressor response to angiotensin II in conscious sheep
16. Hemodynamic, hormonal, and renal effects of adrenomedullin in conscious sheep
17. Adrenomedullin suppresses mitogenesis in rat mesangial cells via cAMP pathway
18. Shear stress augments expression of C-type natriuretic peptide and adrenomedullin
19. Haemodynamic effects of adrenomedullin in human resistance and capacitance vessels
20. Rat-2 fibroblasts express specific adrenomedullin receptors, but not calcitonin-gene-related-peptide receptors, which mediate increased intracellular cAMP, and inhibit mitogen-activated protein kinase activity
21. Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes
22. Expression of adrenomedullin and its serum binding protein in a variety of human cancers: Possible promotion factors of carcinogenesis
23. Effects of low-dose adrenomedullin on cardiac function and systemic haemodynamics in man
24. Adrenomedullin in perinatal medicine
25. Adrenomedullin, a new vasoactive peptide, is increased in preeclampsia
26. Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats
27. Effect of adrenomedullin on renal hemodynamics and functions in dogs
28. Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells
29. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells
30. Adrenomedullin and proadrenomedullin N-terminal 20 peptide in impaired renal function
31. Differential hormonal profiles of adrenomedullin and proadrenomedullin N-terminal 20 peptide in patients with heart failure and effect of treatment on their plasma levels
32. The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer
33. Tissue-specific mRNA expression of a calcitonin receptor-like receptor during fetal, and postnatal development
34. The mechanism of action of PAMPs and their physiological role in controlling G protein coupled receptors
35. Lessons from adrenomedullin knockout mice
36. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: A possible promotion mechanism of carcinogenesis
37. The interaction of CGRP and adrenomedullin with a receptor expressed in the rat pulmonary vascular endothelium
38. Plasma adrenomedullin in diabetes
39. Proadrenomedullin N-terminal 20-peptide (PAMP) receptors, and signal transduction in the rat adrenal gland
40. Differential responses of circulating and tissue adrenomedullin and gene expression to volume overload
41. Mechanisms of adrenomedullin-induced vasodilation in the rat kidney
42. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis
43. Secretion and clearance of the mature form of adrenomedullin in humans
44. Molecular forms of circulating adrenomedullin in patients with congestive heart failure
45. Vasodilation and glomerular binding of adrenomedullin in rabbit kidney are not CGRP receptor mediated
46. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma
47. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP
48. Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failure
49. Genomic structure of human adrenomedullin gene
50. Transcriptional regulation of human adrenomedullin gene in vascular endothelial cells
51. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure
52. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells
53. Diuretic and natriuretic action of adrenomedullin administered intracerebroventricularly in conscious rats
54. Regulation of adrenomedullin production in rat endothelial cells
55. Adrenomedullin as a novel growth-promoting factor for cultured vascular smooth muscle cells: Role of tyrosine kinase-mediated mitogen-activated protein kinase activation
56. Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat
57. Adrenomedullin stimulates proline-rich tyrosine kinase 2 in vascular smooth muscle cells
58. Adrenomedullin stimulates renin release and renin mRNA in mouse juxtaglomerular granular cells
59. Renal localization and actions of adrenomedullin: A natriuretic peptide
60. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure
61. The effect of in vivo gene transfer of prepro-calcitonin gene-related peptide on the pulmonary vascular bed
62. Plasma adrenomedullin levels in the coronary circulation in vasospastic angina pectoris
63. Comparison of bronchodilator responses to adrenomedullin and proadrenomedullin N-terminal 20 peptide
64. Adrenomedullin, a newly discovered hypotensive peptide, is a potent bronchodilator
65. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells
66. Adrenomedullin has mitogenic effects on human oral keratinocytes: Involvement of cyclic AMP
67. Cloning, and expression of cDNA encoding a rat adrenomedullin receptor
68. Identification of an orphan receptor gene as a type 1 calcitonin gene-related peptide receptor
69. Plasma adrenomedullin and natriuretic peptides in patients with essential or malignant hypertension
70. Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide: Its exocytotic secretion, and inhibition of catecholamine secretion in adrenal medulla
71. Increased plasma concentration of adrenomedullin in patients with subarachnoid hemorrhage
72. Impact of NO on ET-1- and AM-induced inotropic responses: Potentiation by combined administration
73. Increased plasma levels of mature adrenomedullin in chronic glomerulonephritis
74. Plasma and urine levels of adrenomedullin and proadrenomedullin N-terminal 20 peptide in chronic glomerulonephritis
75. Short-term modulation of the renin-angiotensin system does not alter plasma adrenomedullin concentration in humans
76. Immunoreactive adrenomedullin in human plasma
77. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP)
78. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma
79. Complete amino acid sequence of porcine adrenomedullin and cloning of cDNA encoding its precursor
80. The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma
81. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin
82. Induction of adrenomedullin during hypoxia in cultured human glioblastoma cells
83. Adrenomedullin receptors in rat cerebral microvessels
84. Selective inhibition of nicotinic receptors by proadrenomedullin N-terminal 12 peptide in bovine adrenal chromaffin cells
85. Increased plasma adrenomedullin in acute myocardial infarction
86. An accelerated increase of plasma adrenomedullin in acute asthma
87. Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells
88. Regulation of rat mesangial cell migration by platelet-derived growth factor (PDGF), angiotensin II, and adrenomedullin
89. Stimulation of cyclic adenosine monophosphate formation by the novel vasorelaxant peptide adrenomedullin in cultured rat mesangial cells
90. Measurement of plasma and urinary adrenomedullin in patients with IgA nephropathy
91. Plasma and urinary levels of adrenomedullin in chronic glomerulonephritis patients with proteinuria
92. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla
93. Increased plasma proadrenomedullin N-terminal 20 peptide in patients with essential hypertension
94. Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling
95. Changes in adrenomedullin plasma concentrations during haemodialysis in patients with chronic renal failure
96. Proadrenomedullin N-terminal 20 peptide (PAMP) immunoreactivity in vertebrate juxtaglomerular granular cells identified by both light, and electron microscopy
97. Identification of a protein that confers calcitonin gene-related peptide responsiveness to oocytes by using a cystic fibrosis transmembrane conductance regulator assay
98. Detection of adrenomedullin, a hypotensive peptide, in amniotic fluid and fetal membranes
99. Renal responses to intra-arterial administration of adrenomedullin in dogs
100. Changes in plasma adrenomedullin levels during the menstrual cycle
101. Immunoreactive adrenomedullin in human fetoplacental tissues
102. Adrenomedullin microinjection into the area postrema increases blood pressure
103. Expression of adrenomedullin in normal human lung and in pulmonary tumors
104. Regulation of insulin secretion and blood glucose metabolism by adrenomedullin
105. Nitric oxide-dependent hypotensive effects of adrenomedullin in rats
106. RAMPs regulate the transport, and ligand specificity of the calcitonin-receptor-like receptor
107. Autocrine/paracrine role of adrenomedullin in cultured endothelial, and mesangial cells
108. Adrenomedullin expression in human tumor cell lines: Its potential role as an autocrine growth factor
109. Expression of proadrenomedullin derived peptides in the mammalian pituitary: Co-localization of follicle stimulating hormone and proadrenomedullin N-20 terminal peptide-like peptide in the same secretory granules of the gonadotropes
110. Expression of adrenomedullin and its receptor during embryogenesis suggests autocrine or paracrine modes of action
111. An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3
112. Role of adrenomedullin system in renal pathophysiology
113. The novel vasoactive hormone, adrenomedullin, inhibits water drinking in the rat
114. Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: Cloning and up-regulation in obstructive nephropathy
115. Hypoxia-induced adrenomedullin production in the kidney
116. The effect of hypothermic cardiopulmonary bypass on plasma adrenomedullin in adult cardiac surgical patients
117. Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure
118. Induction of adrenomedullin by hypoxia and cobalt chloride in human colorectal carcinoma cells
119. Increased plasma adrenomedullin concentrations during cardiac surgery
120. The active molecular form of plasma adrenomedullin is extracted in the pulmonary circulation in patients with mitral stenosis: Possible role of adrenomedullin in pulmonary hypertension
121. Increased plasma levels of adrenomedullin in patients with heart failure
122. Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock
123. A new calcitonin-receptor like sequence in rat pulmonary blood vessels
124. Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats
125. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds
126. Proadrenomedullin N-terminal 20 peptide (PAMP) elevates blood glucose levels via bombesin receptor in mice
127. Decreased gene expression of adrenomedullin receptor in mouse lungs during sepsis
128. The role of adrenomedullin in sepsis
129. Adrenomedullin inhibits transmural pressure induced mesangial cell proliferation through activation of protein kinase A
130. Adrenomedullin-sensitive receptors are preferentially expressed in cultured rat mesangial cells
131. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat
132. Comparison of adrenomedullin with atrial natriuretic peptide in patients with congestive heart failure
133. Regulation of glomerular mesangial cell proliferation in culture by adrenomedullin
134. Cardiovascular actions of adrenomedullin in conscious sheep
135. Presence of immunoreactive adrenomedullin in human and bovine milk
136. Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners
137. Exercise-induced increase in circulating adrenomedullin is related to mean blood pressure in heart transplant recipients
138. Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure
139. Endothelin 1-independent, and angiotensin II-independent induction of adrenomedullin gene expression
140. Central actions of adrenomedullin on cardiovascular parameters and sympathetic outflow in conscious rats
141. Effect of adrenomedullin infusion on basal and stimulated aldosterone secretion in conscious sheep with cervical adrenal autotransplants
142. CGRP, and adrenomedullin receptor populations in human cerebral arteries: In vitro pharmacological, and molecular investigations in different artery sizes
143. Antisense oligonucleotide treatment reveals a physiologically relevant role for adrenomedullin gene products in sodium intake
144. Adrenomedullin inhibits salt appetite
145. Central mechanisms for the hypertensive effects of preproadrenomedullin-derived peptides in conscious rats
146. Proadrenomedullin N-terminal 20 peptide inhibits adrenocorticotropin secretion from cultured pituitary cells, possibly via activation of a potassium channel
147. Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via a cyclic GMP-independent mechanism
148. Characterization of immunoreactive adrenomedullin in human plasma and urine
149. Secretion of adrenomedullin by renal tubular cell lines
150. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma
151. Immunocytochemical localization of adrenomedullin-like immunoreactivity in the human hypothalamus and the adrenal gland
152. Centrally administered adrenomedullin increases plasma oxytocin level with induction of c-fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of the rat
153. Receptor activity modifying proteins
154. Area postrema ablation attenuates activation of neurons in the paraventricular nucleus in response to systemic adrenomedullin
155. Induction of max by adrenomedullin and calcitonin gene-related peptide antagonizes endothelial apoptosis
156. Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and Ca2+ mobilization, in bovine aortic endothelial cells
157. A newly identified peptide, proadrenomedullin N-terminal 20 peptide, induces hypotensive action via pertussis toxin-sensitive mechanisms
158. Proadrenomedullin NH2-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings
159. Pathophysiological assessment of adrenomedullin by mice gene engineering approach
160. Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature
161. CRLR, and RAMPs-receptors for adrenemedullin, and CGRP
162. Adrenomedullin and myocardial contractility in the rat
163. Endothelial cells actively synthesize and secrete adrenomedullin
164. Production and secretion of adrenomedullin from vascular smooth muscle cells: Augmented production by tumor necrosis factor (TNF)-α
165. IL-1, TNF, and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells
166. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide
167. Expression of adrenomedullin mRNA in the human brain and pituitary
168. Presence of adrenomedullin-like immunoreactivity in the human cerebrospinal fluid
169. Proadrenomedullin N-terminal 20 peptide hyperpolarizes the membrane by activating an inwardly rectifying K+ current in differentiated PC12 cells
170. Proadrenomedullin NH2-terminal 20 peptide inhibits the voltage-gated Ca2+ channel current through a pertussis toxin-sensitive G protein in rat pheochromocytoma-derived PC 12 cells
171. Plasma adrenomedullin in various diseases and exercise-induced change in adrenomedullin in healthy subjects
172. Elevated plasma adrenomedullin level in hyperthyroidism
173. The search for the physiologic relevance of AM/PAMP in brain and pituitary gland
174. Human coronary arteriolar dilation to adrenomedullin: Role of nitric oxide and K (+) channels
175. Proadrenomedullin N-terminal 20 peptide (PAMP) stimulates aldosterone secretion by the intact rat adrenal glomerulosa by a cAMP-dependent mechanism
176. Effects of hemodialysis on circulating adrenomedullin concentrations in patients with end-stage renal disease
177. Down-regulated gene expression of renal adrenomedullin receptor complex (RAMP2, RAMP3/CRLR) in rats with 5/6 renal mass ablations
178. Increased gene expression of adrenomedullin and adrenomedullin-receptor complexes, receptor-activity modifying protein (RAMP) 2 and calcitonin-receptor-like receptor (CRLR) in the hearts of rats with congestive heart failure
179. Hemodynamic, hormone, and urinary effects of adrenomedullin infusion in essential hypertension
180. An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth
181. Adrenomedullin; a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes
182. Adrenomedullin in cultured human retinal pigment epithelial cells
183. Physiological role of adrenomedullin on neuroendocrine function
184. Adrenomedullin-immunoreactive neurons in the paraventricular, and supraoptic nuclei of the rat
185. Sequential expression of adrenomedullin, and its receptor during gastric ulcer healing in rats
186. The role of adrenomedullin in cardiovascular responses during sepsis
187. Immunohistochemical identification of adrenomedullin in human, rat, and porcine tissue
188. Plasma concentration of human adrenomedullin in patients on hemodialysis
189. Immunohistochemistry and reverse transcription-PCR for detecting adrenomedullin in the central nervous system
190. Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells
191. Diastolic wall stress and ANG II in cardiac hypertrophy and gene expression induced by volume overload
192. Adrenomedullin inhibits spontaneous and bradykinin-induced but not oxytocin- or prostaglandin F (2alpha)-induced periodic contraction of rat uterus
193. Plasma levels of adrenomedullin in primary and secondary pulmonary hypertension in patients
194. Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive Dahl salt-sensitive rats